Clean air technology provider lists on SIM VSE
03 September 2010 – Indigo Technologies, MD, Gary Sherlock introduces the company, its technology and decision to list on the SIM Venture Securities Exchange
|
|
|
Blackmores full year results
24 August 2010 – (ASX:BKL) CEO Christine Holgate talks about the result - its eighth year of record profits and sales, its move into animal health products and agreement with leading Asian healthcare company Eu Sang Yang.
|
|
|
Phylogica enters into an alliance with AstraZeneca
19 August 2010 – Phylogica Limited (ASX:PYC) Non Executive Director, Nick Woolf explains the company’s shift in focus to contract work and the why major pharma are attracted to its phylomer peptide library.
|
|
|
Motor Traders Association, the battle between dealers and the big manufacturers
10 August 2010 - James McCall, CEO, Motor Traders' Association of NSW, discusses issues surrounding the auto industry, June vehicle sales and the health of ancillary services.
|
|
|
Steve Keen’s view on the housing market
04 August 2010 -Twelve months on, Associate Professor of Economics and Finance at UWS, Steve Keen is unmoved maintaining his view that prices are heading substantially lower.
|
|
|
Major copper & gold mineralisation at Nakru 1
22 July 2010 – Coppermoly (ASX:COY), MD, Peter Swiridiuk discusses drill results, mineralisation at Nakru 1 and similarities with its Nakru 2 tenement.
|
|
|
Vietnam plant update
July 13 2010 – Hazelwood Resources ( ASX: HAZ) MD, Terry Butler-Blaxell reports that the project is on schedule and under budget with the first sales of ferrotungsten from the plant due March quarter of 2011
|
|
|
Fund manager update
13 July 2010 – John Grace, Director of Equity at fund manager Ausbil Dexia talks about the market over the last 12 months, their performance, best picks and outlook for FY 10/ 11.
|
|
|
FY end update
01 July 2010 – Rob Henderson, Chief Economist, NAB gives us an update on how the local economy is tracking at the end of the financial year.
|
|
|
SME Boardroom 12 months of operation
23 June 2010 - SME Boardroom founder, Kim Mei Li Dennis provides an update, talks about Budget outcomes for small to medium sized enterprises and plans for the year ahead.
|
|
|
Unemployment drops in May to 5.2%
11 June 2010 – St George Bank, Chief Economist, Justin Smirk explains the latest figures and provides a year-end forecast.
|
|
|
Barrick Exploration sets up at Nakru 1 ahead of drilling over next 6 months
7 June 2010 – Coppermoly (ASX:COY), MD, Peter Swiridiuk discusses progress with joint venture partner Barrick (PNG) Exploration and its recently acquired new tenements
|
|
|
Kailis Organic Olive Groves to buy assets of Great Southern
04 May 2010 – MD, Mark Kailis talks about its planned acquisition of the Olive Oil assets of Great Southern, its prospectus and marketing opportunities.
|
|
|
Mobilarm to list on ASX
27 April 2010 – CEO Lindsay Lyon explains its solution to man-overboard events for marine based industry.
|
|
|
Helium project for Central Petroleum (ASX:CTP)
23 April 2010 – Central Petroleum, MD, John Heugh, explains its plans to enter the helium market.
|
|
|
Pilbara Minerals Ltd (ASX:PLS)
1 April - Pilbara Minerals Director, Mathew Walker introduces the company, its tenements and decision to raise capital.
|
|
|
NiPlats: Vanadium resource quadruples
1 April– NiPlats Australia Limited (ASX:NIP), Executive Director, Richard Wolanski talks about its Vanadium resource and 2010 plans.
|
|
|
Venture Minerals (ASX:VMS)
24 March 2010 - Venture Minerals (ASX:VMS), MD, Hamish Halliday announces an upgrade to its tin and tungsten project at Mt Lindsay, Tasmania.
|
|
|
Unilife Medical Solutions
5 November 2009 - CEO Alan Shortall talks about its safety syringes, capital raising and plans to list on NASDAQ
|
|
|
Xcelerator Premium Income Limited
28 October 2009 - Managing Director Andy Semple discusses its investment style, results and new issue
|
|
|
Hazelwood capital raising
27 October 2009 - Executive Chairman Mark McAuliffe discusses the results of its recent capital raising.
|
|
|
CBio Limited
22 October 2009 – Dr Göran Ando, Vice Chairman, Danish pharmaceutical company NovoNordisk, talks about its interest in CBio's drug XToll.
|
|
|